lamivudine has been researched along with Diseases, Occupational in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korman, TM; Tapley, N; Woolley, I | 1 |
| Patrick, DM | 1 |
| Chenoweth, CE; Gobetti, JP | 1 |
| Ippolito, G; Puro, V | 1 |
| Alexander, GJ; Bloor, S; Lamy, P; Walsh, KM; Wight, DG; Woodall, T | 1 |
8 other study(ies) available for lamivudine and Diseases, Occupational
| Article | Year |
|---|---|
Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis.
Topics: Adult; Drug Hypersensitivity; Female; Guideline Adherence; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Needlestick Injuries; Occupational Diseases; Occupational Exposure; Zidovudine | 2003 |
HIV postexposure prophylaxis: new recommendations.
Topics: Anti-HIV Agents; Blood-Borne Pathogens; Chemoprevention; Drug Combinations; Guidelines as Topic; Health Personnel; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Zidovudine | 1997 |
Postexposure chemoprophylaxis for occupational exposure to HIV in the dental office.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Child; Dental Auxiliaries; Dentists; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; United States; United States Public Health Service; Universal Precautions; Zidovudine | 1997 |
Brief report: effect of antiretroviral agents on T-lymphocyte subset counts in healthy HIV-negative individuals. The Italian Registry on Antiretroviral Postexposure Prophylaxis.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Health Personnel; HIV Infections; HIV Seronegativity; Humans; Lamivudine; Longitudinal Studies; Lymphocyte Count; Male; Occupational Diseases; Retrospective Studies; T-Lymphocyte Subsets; Zidovudine | 2000 |
Experience with PEP finds most patients stop early.
Topics: Anti-HIV Agents; British Columbia; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Male; Occupational Diseases; Patient Compliance; Sexually Transmitted Diseases; Time Factors; United States; Zidovudine | 1997 |
Updated postexposure guidelines stress need for expert advice.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; Female; Guidelines as Topic; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Occupational Diseases; Occupational Exposure; Pregnancy; Registries; United States; Zidovudine | 1998 |
Registry finds 3 drugs most favored PEP regimen.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Combinations; Drug Therapy, Combination; Guidelines as Topic; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Registries; United States; Zidovudine | 1998 |
Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus.
Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Occupational Diseases; Organophosphonates; Treatment Outcome | 2001 |